NASDAQ:AUXL - Auxilium Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$36.47 0.00 (0.00 %)
(As of 10/15/2018 04:00 PM ET)
Previous Close$36.47
Today's RangeN/A
52-Week Range$17.10 - $37.92
VolumeN/A
Average Volume1.32 million shs
Market Capitalization$1.85 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.66
Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company that focuses on developing and marketing products to predominantly specialist audiences. Its core therapeutic focus continues to be in the area of urology, with an anchor position in men's healthcare. The company's products include Testim (testosterone gel) and testosterone gel are indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; TESTOPEL offers men an option that provides a long-acting androgenic effect; Striant (testosterone buccal system) CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone; STENDRA is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction; among others.

Receive AUXL News and Ratings via Email

Sign-up to receive the latest news and ratings for AUXL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryPharmaceuticals
SectorN/A
SymbolNASDAQ:AUXL
CUSIP05334D10
Phone+1-484-3215900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-29.78%
Return on Equity-76.75%
Return on Assets-11.59%

Miscellaneous

EmployeesN/A
Outstanding Shares51,020,000
Market Cap$1.85 billion

Auxilium Pharmaceuticals (NASDAQ:AUXL) Frequently Asked Questions

What is Auxilium Pharmaceuticals' stock symbol?

Auxilium Pharmaceuticals trades on the NASDAQ under the ticker symbol "AUXL."

How were Auxilium Pharmaceuticals' earnings last quarter?

Auxilium Pharmaceuticals Inc (NASDAQ:AUXL) announced its earnings results on Thursday, October, 30th. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.30. The biopharmaceutical company had revenue of $109.60 million for the quarter, compared to analysts' expectations of $101.02 million. Auxilium Pharmaceuticals had a negative return on equity of 76.75% and a negative net margin of 29.78%. Auxilium Pharmaceuticals's quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.17 earnings per share. View Auxilium Pharmaceuticals' Earnings History.

How do I buy shares of Auxilium Pharmaceuticals?

Shares of AUXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Auxilium Pharmaceuticals' stock price today?

One share of AUXL stock can currently be purchased for approximately $36.47.

How big of a company is Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals has a market capitalization of $1.85 billion.

What is Auxilium Pharmaceuticals' official website?

The official website for Auxilium Pharmaceuticals is http://www.auxilium.com.

How can I contact Auxilium Pharmaceuticals?

Auxilium Pharmaceuticals' mailing address is 640 Lee Rd, CHESTERBROOK, PA 19087-5636, United States. The biopharmaceutical company can be reached via phone at +1-484-3215900.


MarketBeat Community Rating for Auxilium Pharmaceuticals (NASDAQ AUXL)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  243 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  423
MarketBeat's community ratings are surveys of what our community members think about Auxilium Pharmaceuticals and other stocks. Vote "Outperform" if you believe AUXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AUXL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel